Jing Xu is an Investment Principal at LYFE Capital, whose known portfolio counts 14 companies.
Is Jing Xu a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- HardwareHealthcare
- Focus
- BiotechClinical TrialsDiagnosticsDrug DiscoveryGenomicsHealthcare Supply ChainMedTechMedical DevicesPharmaceuticalsTranspacific
Contacts
Affiliated funds' portfolios
Investment Principal at LYFE Capital, whose known portfolio counts 14 companies
- Neurona Therapeutics
- Aspen Neuroscience
- Precision BioSciences
- Kyverna Therapeutics
- CytoTronics
- Elite Technology
- HC Scientific
- ProfoundBio
- Starna Therapeutics
- Verdiva Bio
- ALLYRNA Pharmaceuticals
- Exegenesis Bio
- and 2 more
Investor Profile
Founders in the listed sectors Hardware and Healthcare, and focus areas Biotech, Clinical Trials, Diagnostics and Drug Discovery fall inside that listing.
Stage-wise, the deals at LYFE Capital cluster around Growth, Late-Stage and Pre-Seed rounds.
The firm portfolio and the focus above give founders context on whether Jing Xu matches their raise.
Colleagues at LYFE Capital
James Zhao
Founding Partner
Menlo Park, United States
Yao Ho
Managing Director
Menlo Park, United States
Jack Chen
Managing Partner
Singapore
Fong Ming Koh
Principal
Singapore
Chen Long William
Partner
Singapore
Yinan Wang
Principal
Singapore
Frank Ouyang
Vice President
Jing'an District, China
Chloe Mo
Managing Director
Hong Kong
Frequently asked questions
Who is Jing Xu?
Jing Xu is a private equity investor based in Singapore, listed as Investment Principal at LYFE Capital. The known portfolio of that firm counts 14 companies. That portfolio belongs to the firm, not to Jing Xu personally.
What does Jing Xu invest in?
Listed sectors include Hardware and Healthcare; listed focus areas include Biotech, Clinical Trials, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Jing Xu invest at?
LYFE Capital appears in Growth, Late-Stage and Pre-Seed rounds across its known deals, and Jing Xu is listed there as Investment Principal. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Jing Xu listed at?
Jing Xu is listed as Investment Principal at LYFE Capital. 8 other people in the database share a firm with Jing Xu.
How do I contact Jing Xu?
An email address, a phone number and a LinkedIn page are on file for Jing Xu. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal